Publications of F. Weber

Weber, F.; Luke, W.; Weber, T.: Progressive multifocal leukencephalopathy - Diagnosis, pathogenesis, and therapeutic options. Aktuelle Neurologie 31 (1), pp. 19 - 26 (2004)

Flachenecker, P.; Bihler, I.; Weber, F.; Gottschalk, M.; Toyka, K. V.; Rieckmann, P.: Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Multiple Sclerosis 10 (2), pp. 165 - 169 (2004)

Mirowska, D.; Wicha, W.; Czlonkowski, B. A.; Czlonkowski, A.; Weber, F.: Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone. Journal of Neuroimmunology 146 (1-2), pp. 171 - 175 (2004)

Weber, F.: Störungen von Affekt und Kognition bei Patienten mit Multipler Sklerose. Nervenheilkunde 23 (2), pp. 94 - 98 (2004)

Yushchenko, M.; Mader, M.; Elitok, E.; Bitsch, A.; Dressel, A.; Tumani, H.; Bogumil, T.; Kitze, B.; Poser, S.; Weber, F.: Interferon-beta-1b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. Journal of Neurology 250 (10), pp. 1224 - 1228 (2003)

Mirowska, D.; Wicha, W.; Czlonkowski, A.; Czlonkowska, A.; Holsboer, F.; Weber, F.: Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone. Pharmacopsychiatry 36 (5), p. 247 - 247 (2003)

Brettschneider, J.; Ecker, D.; Bitsch, A.; Bahner, D.; Bogumil, T.; Dressel, A.; Elitok, E.; Kitze, B.; Poser, S.; Weber, F. et al.; Tumani, H.: The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b. Journal of Neuroimmunology 133 (1-2), pp. 193 - 197 (2002)

Felkel, C.; Schöll, U.; Mäder, M.; Schwartz, P.; Felgenhauer, K.; Hardeland, R.; Beuche, W.; Weber, F.: Migration of human granulocytes through reconstituted basement membrane is not dependent on matrix metalloproteinase-9 (MMP-9). Journal of Neuroimmunology 116, pp. 49 - 55 (2001)

Maliszewska, M.; Mäder, M.; Schöll, U.; Azeh, I.; Hardeland, R.; Felgenhauer, K.; Beuche, W.; Weber, F.: Development of an ultrasensitive enzyme immunoassay for the determination of matrix metalloproteinase-9 (MMP-9) levels in normal human cerebrospinal fluid. Journal of Neuroimmunology 116, pp. 233 - 237 (2001)

Weber, F.: Multiple Sklerose. Experimentelle Therapien - Hoffnung für die Zukunft? Neurotransmitter 3, pp. 61 - 64 (2001)

Weber, F.; Neurath, H.; Desel, H.; Kitze, B.; Prange, H.: Rhabdomyolyse nach Einnahme von Venlafaxin (Trevilor®). Aktuelle Neurologie 28, pp. 132 - 134 (2001)

Weber, F.; Bitsch, A.; Prange, H.: Koma - Metabolische Störungen - Hirntod. In: Die Intensivmedizin. 10., überarb. u. erw. Aufl., pp. 635 - 643 (Eds. Burchardi, H.; Larsen, R.; Kuhlen, R.; Jauch, K.-W.; Schölmerich, J.). Springer, Heidelberg (2008)

Weber, F.: Multiple Sklerose: Pathogenese und Möglichkeiten einer individualisierten Therapie. Forschungsbericht 2007 - Max-Planck-Institut für Psychiatrie. In: Jahrbuch (Ed. Max-Planck-Gesellschaft). Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., München (2007)

Weber, F.: Postinfektiöse und postvakzinale ZNS-Erkankungen. In: Infektionserkrankungen des Zentralnervensystems. Pathogenese, Diagnose und Therapie. 2. völlig neu bearb. Aufl, pp. 169 - 183 (Eds. Prange, H.; Bitsch, A.). Wissenschaftliche Verlagsgesellschaft, Stuttgart (2001)

Abrahamyan, S.; Eberspaecher, B.; Ambrosius, B.; Hessler, N.; Antony, G.; Koenig, I. R.; Hoshi, M. -.; Aly, L.; Luessi, F.; Groppa, S. et al.; Klotz, L.; Meuth, S. G.; Tackenberg, B.; Stoppe, M.; Bergh, F. T.; Tumani, H.; Kuempfel, T.; Stangel, M.; Heesen, C.; Wildemann, B.; Paul, F.; Bayas, A.; Warnke, C.; Weber, F.; Linker, R. A.; Ziemann, U.; Zettl, U. K.; Zipp, F.; Wiendl, H.; Hemmer, B.; Gold, R.; Salmen, A.; Ruprecht, K.: Absence of Epstein-Barr virus seronegativity in a large cohort of patients with early multiple sclerosis. 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, GERMANY, October 10, 2018 - October 12, 2018. MULTIPLE SCLEROSIS JOURNAL 24 (Suppl. 2), 320, pp. 981 - 982 (2018)

Gasperi, C.; Salmen, A.; Antony, G.; Bayas, A.; Dankowski, T.; Heesen, C.; Kümpfel, T.; Linker, R. A.; Paul, F.; Stangel, M. et al.; Tackenberg, B.; Bergh, F. T.; Tumani, H.; Warnke, C.; Weber, F.; Wiendl, H.; Wildemann, B.; Zettl, U. K.; Ziemann, U.; Zipp, F.; Gold, R.; Hemmer, B.: Intrathecal immunoglobulin synthesis as a predictive marker for disability progression in multiple sclerosis. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple-Scle rosis (ACTRIMS), Paris, FRANCE, October 25, 2017 - October 28, 2017. MULTIPLE SCLEROSIS JOURNAL 23 (3, Suppl.), P643, pp. 301 - 303 (2017)

Gonzalez-Escamilla, G.; Jaeckle, J.; Graetz, C.; Fleischer, V.; Kroth, J.; Antony, G.; Bellenberg, B.; Berthele, A.; Biberacher, V.; Gold, R. et al.; Hecker, M.; Hohlfeld, R.; Jahn, A.; Kirschke, J. S.; Kuempfel, T.; Linker, R. A.; Lukas, C.; Muehlau, M.; Pfeuffer, S.; Salmen, A.; Weber, F.; Wiendl, H.; Zettl, U. K.; Meuth, S.; Lill, C. M.; Muthuraman, M.; Zipp, F.; Groppa, S.: Altered grey matter networks in young patients with MS at genetic risk for Alzheimer's disease. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, FRANCE, October 25, 2017 - October 28, 2017. MULTIPLE SCLEROSIS JOURNAL 23 (3, Suppl.), P412, pp. 167 - 168 (2017)

Graetz, C.; Gröger, A.; Salmen, A.; Zöller, D.; Schultz, J.; Siller, N.; Luessi, F.; Fleischer, V.; Bellenberg, B.; Berthele, A. et al.; Biberacher, V.; Havla, J.; Hecker, M.; Hohlfeld, R.; Infante-Duarte, C.; Kirschke, J. S.; Kuempfel, T.; Linker, R.; Paul, F.; Pfeuffer, S.; Saemann, P.; Weber, F.; Zettl, U. K.; Jahn-Eimermacher, A.; Antony, G.; Sergiu, G.; Wiendl, H.; Hemmer, B.; Muehlau, M.; Lukas, C.; Gold, R.; Lill, C. M.; Zipp, F.: Association of smoking but not HLA-DRB1*15:01, APOE, or body mass index with brain atrophy in early multiple sclerosis. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Scle rosis (ACTRIMS), Paris, FRANCE, October 25, 2017 - October 28, 2017. MULTIPLE SCLEROSIS JOURNAL 23 (3, Suppl.), P444, pp. 184 - 185 (2017)

von Bismarck, O.; Dankowski, T.; Antony, G.; Ambrosius, B.; Ziegler, A.; Zipp, F.; Tackenberg, B.; Bergh, F. T.; Tumani, H.; Kuempfel, T. et al.; Stangel, M.; Heesen, C.; Wildemann, B.; Paul, F.; Bayas, A.; Warnke, C.; Weber, F.; Linker, R. A.; Ziemann, U.; Zettl, U. K.; Wiendl, H.; Hemmer, B.; Gold, R.; Salmen, A.: Neuropsychological impairment in newly diagnosed early multiple sclerosis: clinical and neuropsychological characterization of a German cohort of 1124 patients. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, October 25, 2017 - October 28, 2017. MULTIPLE SCLEROSIS JOURNAL 23 (Suppl. 3), P411, pp. 165 - 166 (2017)

Gasperi, C.; Krysta, A.; Antony, G.; Bayas, A.; Gold, R.; Heesen, C.; Kuempfel, T.; Linker, R. A.; Paul, F.; Stangel, M. et al.; Tackenberg, B.; Bergh, F. T.; Tumani, H.; Warnke, C.; Weber, F.; Wick, W.; Wiendl, H.; Zettl, U. K.; Ziemann, U.; Zipp, F.; Buck, D.; Hemmer, B.: Genetic variants associated with intrathecal synthesis of IgG, IgM and IgA in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL, 22, pp. 486 - 487. 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, ENGLAND, September 14, 2016 - September 17, 2016. (2016)